Drug Safety Information for INAPSINE (Droperidol)

Adverse Drug Reactions for INAPSINE* (Droperidol)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with INAPSINE
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Renal failure acute77
2Pain52
3Nausea49
4Hypotension44
5Anxiety*44
6Dyspnoea43
7Vomiting38
8Haematuria38
9Death37
10Oliguria33
11Tachycardia32
12Pyrexia28
13Depression27
14Toxicity to various agents27
15Drug interaction26
16Cardiac arrest26
17Drug hypersensitivity25
18Overdose24
19Hyperhidrosis24
20Bradycardia23

* This side effect also appears in "Top 10 Side Effects of INAPSINE " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking INAPSINE
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Product used for unknown indication618
2Nausea*168
3Anaesthesia78
4Ill-defined disorder59
5Pain57
6Prophylaxis of nausea and vomiting53
7Vomiting50
8General anaesthesia49
9Sedation*47
10Migraine*38

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for INAPSINE

Total Reports Filed with FDA: 4880


Number of FDA Adverse Event Reports by Patient Age for INAPSINE

Total Reports Filed with FDA: 4880*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Droperidol (Droleptan, Dehydrobenzperidol, Inapsine, Droperidol)

Charts are based on 4880 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and INAPSINE Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.